Search results
USFDA approves second Alzheimer's drug that can modestly slow disease
Business Standard India· 1 day agoThe Food and Drug Administration approved Eli Lilly's Kisunla on Tuesday for mild or early cases of...
New Alzheimer’s drug wins approval after FDA delay
Deseret News· 1 day agoA sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. The U.S. Food and Drug Administration on Tuesday,...
Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease
Pharmaceutical Technology· 2 days agoEisai and Biogen must now brace for competition as the US Food and Drug Administration (FDA) has...
US weight loss drug gets expert panel nod
Indian Express· 2 days agoThe popular weight loss and diabetes drug Tirzepatide — marketed as Mounjaro and Zepbound in the US — is likely to hit the markets in India though there...
India approves 2 weight loss drugs — Mounjaro and Zepbound: Here’s all you need to know
Indian Express· 2 days agoApplication for obesity indication is undergoing review by CDSCO. The committee has approved the...
Eli Lilly Alzheimer's drug approved by US FDA
Hindustan Times· 2 days agoThe U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second therapy for slowing...
FTC investigates Teva over contested product patents
Pharmaceutical Technology· 2 days agoIn recent years, Teva has had to navigate choppy patent waters. In September 2023, a District Judge sided with Eli Lilly in a patent infringement...
Eli Tomac Aims for AMA Pro Motocross Comeback at Budds Creek
Motocross· 2 days agoA crash at the Denver Monster Energy AMA Supercross resulted in a Bennetts fracture and some torn...
Eli Lilly continues radiopharma push with $140m Radionetics partnership
Pharmaceutical Technology· 2 days agoEli Lilly has partnered with Radionetics Oncology in a $140m deal, as the drugmaker aims to get a...
Lilly drug for Alzheimer’s approved by FDA
BioPharma Dive· 2 days agoThe drug, which Lilly will sell as Kinsunla, carries a warning for the risk of a certain kind of imaging abnormality that can be serious in rare cases.
